Cargando…

P092 Otilonium bromide is a potent antifungal agent against fluconazole- and flucytosine-resistant Cryptococcus neoformans strains

POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Cryptococcus neoformans is a worldwide threat causing global pulmonary and systemic infections in humans. However, only three drugs are available for the treatment of cryptococcosis: fluconazole, amphotericin B, and flucytosine....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhen, Cheng, Lu, Hui, Jiang, Yuan-ying, Yang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509988/ http://dx.doi.org/10.1093/mmy/myac072.P092

Ejemplares similares

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

S3.5d Identification of fungicidal activity of otilonium bromide by the repurposing approach
por: Zhen, Cheng, et al.
Publicado: (2022)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations
por: Melendres, Javier, et al.
Publicado: (2022)

Carbon Dioxide Potentiates Flucytosine Susceptibility in Cryptococcus neoformans
por: Jezewski, Andrew J., et al.
Publicado: (2023)

Repurposing Antispasmodic Agent Otilonium Bromide for Treatment of Staphylococcus aureus Infections
por: Zhou, Linying, et al.
Publicado: (2020)

P271 A masquerading case of Cryptococcus neoformans
por: S, Divyashree, et al.
Publicado: (2022)

S5.3a Unraveling the genetic determinants of virulence in Cryptococcus neoformans
por: Jackson, Katrina, et al.
Publicado: (2022)

P379 Antifungal activity of α defensins 5 like peptide against Cryptococcus neoformans var. grubii and in silico designing of its peptidomimetics
por: Singh, Karuna, et al.
Publicado: (2022)

Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans
por: Bhattacharya, Somanon, et al.
Publicado: (2021)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin
por: McHale, Thomas, et al.
Publicado: (2023)

P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia
por: Becerra-Alvarez, Paola, et al.
Publicado: (2022)

Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents
por: Pereira de Sa, Nivea, et al.
Publicado: (2021)

Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans
por: Rizzo, Juliana, et al.
Publicado: (2023)

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

O092: Clean hands: an university extension project
por: Tipple, AFV, et al.
Publicado: (2013)

Antifungal activity of liriodenine on clinical strains of Cryptococcus neoformans and Cryptococcus gattii species complexes
por: Levorato-Vinche, Adriele Dandara, et al.
Publicado: (2022)

P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans
por: Aslani, Narges
Publicado: (2022)

P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan
por: Abdalla, Wisal
Publicado: (2022)

P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans
por: Aggarwal, Rashi, et al.
Publicado: (2022)

Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro
por: Peng, Congyue Annie, et al.
Publicado: (2018)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans
por: Oliveira, Natalia Kronbauer, et al.
Publicado: (2022)

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC(50)
por: Gerlach, Elliot S., et al.
Publicado: (2021)

The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome
por: Chang, Full-Young, et al.
Publicado: (2011)

Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis
por: Clavé, Pere, et al.
Publicado: (2017)

Colony and Single Cell Level Analysis of the Heterogeneous Response of Cryptococcus neoformans to Fluconazole
por: Altamirano, Sophie, et al.
Publicado: (2018)

Necrotizing fasciitis as the initial presentation of disseminated infection with fluconazole-resistant Cryptococcus neoformans
por: Richardson, Timothy E, et al.
Publicado: (2014)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans
por: Dbouk, Nadir Hani, et al.
Publicado: (2019)

S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy
por: Sun, Liuliu, et al.
Publicado: (2022)

Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine
por: Al-Sweih, Noura, et al.
Publicado: (2014)

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Is Otilonium Bromide Really Effective for Treating Asian Patients With Irritable Bowel Syndrome?
por: Kim, Ji Won
Publicado: (2012)

Interactions between antifungals and everolimus against Cryptococcus neoformans
por: Liang, Pin, et al.
Publicado: (2023)

Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii
por: Jones, Tyler H., et al.
Publicado: (2017)

Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans
por: Ngamskulrungroj, Popchai, et al.
Publicado: (2012)

Otilonium bromide boosts antimicrobial activities of colistin against Gram-negative pathogens and their persisters
por: Xu, Chen, et al.
Publicado: (2022)

Antifungal potential of punicalagin against Cryptococcus neoformans species complex
por: Silva, Thaísa Cristina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0s1ud4uqa6c8dt40d32uvqspv7